Comparison of low-dose human menopausal gonadotropin and micronized 17β-estradiol supplementation in in vitro maturation cycles with thin endometrial lining
To access this article, please choose from the options below
S.E.E. has nothing to disclose. W.-Y.S. has nothing to disclose. R.Y. has nothing to disclose. Y.G. has nothing to disclose. D.L. has nothings to disclose. E.D. has nothing to disclose. S.-L-T. has nothing to disclose.
PII: S0015-0282(08)03270-6
doi:10.1016/j.fertnstert.2008.07.1750
© 2009 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

